-Substituted -amino acids, -substituted -amino acid derivatives, and -substituted -amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the -substituted -amino acid derivatives and -substituted -amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.

Mixtures of diphosphinic acids and alkylphosphinic acids, a process for preparation thereof and use thereof

The invention relates to mixtures of at least one diphosphinic acid of the formula (I)

##STR00001##

in which R.sup.1, R.sup.2 are each H, C.sub.1-C.sub.18-alkyl, C.sub.2-C.sub.18-alkenyl, C.sub.6-C.sub.18-aryl, C.sub.7-C.sub.18-alkylaryl R.sup.4 is C.sub.1-C.sub.18-alkylene, C.sub.2-C.sub.18-alkenylene, C.sub.6-C.sub.18-arylene, C.sub.7-C.sub.18-alkylarylene
with at least one alkylphosphinic acid of the formula (II)

##STR00002##

in which R.sup.3 is C.sub.1-C.sub.18-alkyl, C.sub.2-C.sub.18-alkenyl, C.sub.6-C.sub.8-aryl, C.sub.7-C.sub.18-alkylaryl.

The invention also relates to a process for preparing these mixtures and to the use thereof.

-Substituted -amino acids, -substituted -amino acid derivatives, and -substituted -amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the -substituted -amino acid derivatives and -substituted -amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.

-Substituted -amino acids, -substituted -amino acid derivatives, and -substituted -amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates, capable of passing through the blood-brain barrier, and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres and methods of using the compounds for treating tumors are also disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres exhibit an improved selectivity toward tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres exhibit an increased efficacy on a variety of tumor types.

-Substituted -amino acids, -substituted -amino acid derivatives, and -substituted -amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates, capable of passing through the blood-brain barrier, and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres and methods of using the compounds for treating tumors are also disclosed. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres exhibit an improved selectivity toward tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The -substituted -amino acid derivatives and -substituted -amino acid analogs and (bio)isosteres exhibit an increased efficacy on a variety of tumor types.

Provided are a compound and a metal extractant represented by Formula (I), and a separation recovery method of metal ions using the metal extractant.

##STR00001##

In Formula (I), R.sup.1 and R.sup.2 each independently represent a substituent having a molecular weight of 100 or higher, in which at least one of the substituents has a molecular weight of 160 or higher. Y.sup.P represents a sulfur atom or an oxygen atom. Z represents a hydroxy group, a sulfanyl group, or a hydroxyaryl group. L represents a single bond, in which in a case where n represents 2 or more, L interposed between two adjacent P's represents a single bond or a linking group. n represents an integer of 1 to 6.